155696-77-8

Upstream product

• 1707-77-3 1,2:5,6-di-O-isopropylidene-D-mannitol 
• 111476-62-1 3,4-di-O-benzyl-1,2:5,6-di-O-isopropylidene-D-mannitol 
• 100-44-7 benzyl chloride 
• 36199-02-7 3,4-di-O-benzyl-D-mannitol 
• 313355-01-0 (2R,3R,4R)-1-Azido-3,4-bis-benzyloxy-4-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-butan-2-ol 

Downstream Products

• 155696-78-9 6-azido-3,4-di-O-benzyl-6-deoxy-β-D-fructofuranose 
• 171973-88-9 2,5-anhydro-6-azido-3,4-di-O-benzyl-6-deoxy-D-glucitol 
• 746656-98-4 3,4-bis-benzyloxy-5-(tert-butoxycarbonylamino-methyl)-tetrahydro-furan-2-carboxylic acid tert-butyl ester 
• 746656-97-3 N-Boc-6-amino-2,5-anhydro-3,4-di-O-benzyl-6-deoxy-D-glucitol 

Relevant academic research and scientific papers

An efficient conversion of D-mannitol into D-fructose and 1,5-dideoxy-1,5-imino-D-mannitol (1-deoxymannojirimycin)

The utility of bis(tributyltin)oxide-bromine for the selective oxidation of secondary hydroxyl groups in the presence of primary hydroxyl groups has been further demonstrated by the efficient conversions of D-mannitol into D-fructose and 1,5-dideoxy-1,5-imino-D-mannitol (1-deoxymannojirimycin).

Synthesis and conformational studies of 3,4-di-O-acylated furanoid sugar amino acid-containing analogs of the receptor binding inhibitor of vasoactive intestinal peptide

Structural analysis of the di-O-caprylated Gaa-containing analog of the receptor binding inhibitors of vasoactive intestinal peptide by various NMR techniques and constrained molecular dynamics (MD) simulation studies established a well-defined β-turn str